Low Prevalence of Cardiac Sarcoidosis Using Routine and Enhanced Screening Strategies in Unselected Sarcoidosis Patients: Preliminary Baseline Data from the Foundation for Sarcoidosis Research Clinical Studies Network Screening Trial
D.A. Culver, Lisa Maier(University of Tübingen), A. Wimer(Cleveland Clinic), Marcel Veltkamp(University Medical Center Utrecht), Nabeel Hamzeh(American Thoracic Society), Tamara Al-Hakim(Pulmonary Fibrosis Foundation), T. Shivas(Pulmonary Fibrosis Foundation), Marc A. Judson(Cleveland Clinic), Susan Elizabeth Gole(Cleveland Clinic), Peter H. S. Sporn(Northwestern University), Nadera Sweiss(University of Illinois Chicago), M.L. Ribeiro Neto(Cleveland Clinic), Sumit Josh(Cleveland Clinic), R.P. Baughman(University of Cincinnati), C. Hamilton(Pulmonary Fibrosis Foundation), Muhunthan Thillai(Papworth Hospital)
Cited by 0
Related Papers
Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|1k
Practice Guidelines for Diseases Caused by Aspergillus
|Clinical Infectious Diseases|2000|797
ERS clinical practice guidelines on treatment of sarcoidosis
|European Respiratory Journal|2021|579
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
|PubMed|2014|505
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503